{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T07:00:44Z","timestamp":1764745244355,"version":"3.46.0"},"reference-count":41,"publisher":"Touch Medical Media, Ltd.","issue":"1","license":[{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"This article is published under the Creative Commons Attribution Non-commercial License."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"abstract":"<p\/>","DOI":"10.17925\/hi.2021.15.1.54","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T12:10:52Z","timestamp":1628770252000},"page":"54","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive Review of Complete Versus Culprit-only Revascularization for Multivessel Disease in ST-segment Elevation Myocardial Infarction"],"prefix":"10.17925","volume":"15","author":[{"given":"Robin","family":"Jacob","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Division of Cardiology, University of Texas Health Science Center at Houston, TX, USA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaaz K","family":"Sachedina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Division of Cardiology, University of Texas Health Science Center at Houston, TX, USA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7274","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Park DW, Clare RM, Schulte PJ, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction.\n                      JAMA\n                      . 2014;312:2019\u201327.","DOI":"10.1001\/jama.2014.15095"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Soraja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.\n                      Eur Heart J\n                      . 2007;28:1709\u201316.","DOI":"10.1093\/eurheartj\/ehm184"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Toutouzas K, Drakopoulou M, Mitropoulos J, et al. Elevated plaque temperature in non-culprit de novo atheromatous lesions of patients with acute coronary syndrome.\n                      J Am Coll Cardiol\n                      . 2006;47:301\u20136.","DOI":"10.1016\/j.jacc.2005.07.069"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction.\n                      N Engl J Med\n                      . 2000;343:915\u201322.","DOI":"10.1056\/NEJM200009283431303"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study.\n                      Circulation\n                      . 2002;106:804\u20138.","DOI":"10.1161\/01.CIR.0000025609.13806.31"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Parodi G, Mernisha G, Valenti R, et al. Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience.\n                      Heart\n                      . 2005;91:1541\u20134.","DOI":"10.1136\/hrt.2004.054692"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Jaguszewski M, Radovanovic D, Nallamothu BK, et al. Multivessel versus culprit vessel percutaneous coronary intervention in ST elevation myocardial infarction: is more worse?\n                      EuroIntervention\n                      . 2013;9:909\u201315.","DOI":"10.4244\/EIJV9I8A153"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Santos AR, Picarra BC, Celeiro M, et al. Multivessel approach in ST elevation myocardial infarction: impact on in hospital morbidity and mortality.\n                      Rev Port Cardiol\n                      . 2014;33:67\u201373.","DOI":"10.1016\/j.repc.2013.07.015"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Iqbal MB, Ilsley C, Kabir T, et al. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST segment elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.\n                      Circ Cardiovasc Quality Outcomes\n                      . 2014;7:936\u201343.","DOI":"10.1161\/CIRCOUTCOMES.114.001194"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Hannan EL, Samadashvili Z, Walford G, et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.\n                      JACC Cardiovasc Interv\n                      . 2010;3:22\u201331.","DOI":"10.1016\/j.jcin.2009.10.017"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Abe D, Sato A, Hoshi T, et al. Initial culprit-only versus initial multivessel percutaneous coronary intervention in patients with ST segment elevation myocardial infarction: results from the Ibaraki Cardiovascular Assessment Study registry.\n                      Heart Vessels\n                      . 2014;29:171\u20137.","DOI":"10.1007\/s00380-013-0342-1"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Lee JM, Rhee TM, Hahn JY, et al. Multivessel percutaneous coronary intervention in patients with STEMI with cardiogenic shock.\n                      J Am Coll Cardiol\n                      . 2018;71:844\u201356.","DOI":"10.1016\/j.jacc.2017.12.028"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Cavender MA, Milford-Beland S, Roe MT, et al. prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry).\n                      Am J Cardiol\n                      . 2009;104:507\u201313.","DOI":"10.1016\/j.amjcard.2009.04.016"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Russo JJ, Wells GA, Chong AY, et al. Safety and efficacy of staged percutaneous coronary intervention during index admission for ST-elevation myocardial infarction with multivessel coronary disease (insights from the University of Ottawa Institute STEMI Registry).\n                      Am J Cardiol\n                      . 2015;116:1157\u201362.","DOI":"10.1016\/j.amjcard.2015.07.029"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Chen HC, Tsai TH, Fang HY, et al. Benefit of revascularization in non infarct related artery multivessel disease patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.\n                      Int Heart Journal\n                      . 2010;51:319\u201324.","DOI":"10.1536\/ihj.51.319"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Toyota T, Shiomi H, Taniguchi T, et al. Culprit vessel-only vs. staged multivessel percutaneous coronary intervention strategies in patients with multivessel coronary artery disease undergoing primary percutaneous coronary intervention ST-segment elevation myocardial infarction.\n                      Circ J\n                      . 2016;80:371\u20138.","DOI":"10.1253\/circj.CJ-15-0493"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Manari A, Varani E, Guastaroba MS, et al. Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies: insights from the REAL Registry.\n                      Catheter Cardiovasc Interv\n                      . 2014;84:912\u201322.","DOI":"10.1002\/ccd.25374"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Politi L, Sgura F, Rossi R, et al. A randomized trial of target-vessel versus multivessel revascularization in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow up.\n                      Heart\n                      . 2010;96:662\u20137.","DOI":"10.1136\/hrt.2009.177162"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Di Mario C, Mara S, Flavio A, et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomized HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELPAMI) Study.\n                      Int J Cardiovasc Intervent\n                      . 2004;6:128\u201333.","DOI":"10.1080\/14628840310030441"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction.\n                      N Engl J Med\n                      . 2013;369:1115\u201323.","DOI":"10.1056\/NEJMoa1305520"},{"key":"ref21","unstructured":"Hlinomaz O, Groch L, Polokova K, et al. Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: complete revascularization versus conservative strategy. PRAGUE 13 trial.\n                      Kardiologicka revue\n                      . 2015;17:214\u201320."},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.\n                      J Am Coll Cardiol\n                      . 2015;65:963\u201372.","DOI":"10.1016\/j.jacc.2014.12.038"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Ghani A, Dambrink JHE, Hof WJ, et al. Treatment of non-culprit lesions detected during primary PCI: long-term follow up of a randomized clinical trial.\n                      Neth Heart J\n                      . 2012;20:347\u201353.","DOI":"10.1007\/s12471-012-0281-y"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Engstr\u00f8m T, Kelb\u00e6k H, Helqvist S, et al. Complete revascularization versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3\u2014 PRIMULTI): an open-label, randomized controlled trial.\n                      Lancet\n                      . 2015;386:665\u201371.","DOI":"10.1016\/S0140-6736(15)60648-1"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Smits PC, Abdel-Wahab M, Neumann FJ, et al. Fractional flow reserve guided multivessel angioplasty in myocardial infarction.\n                      N Engl J Med\n                      . 2017;376:1234\u201344.","DOI":"10.1056\/NEJMoa1701067"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Mehta SR, Wood DA, Storey RF, et al. Complete revascularization with multivessel PCI for myocardial infarction.\n                      N Engl J Med\n                      . 2019;381:1411\u201321.","DOI":"10.1056\/NEJMoa1907775"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Thiele H, Akin I, Sandri M, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock.\n                      N Engl J Med\n                      . 2017;377:2419\u201332.","DOI":"10.1056\/NEJMoa1710261"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Hamza M, Mahmoud N, Elgendy IY. A randomized trial of complete versus culprit-only revascularization during primary percutaneous coronary intervention in diabetic patients with acute ST elevation myocardial infarction and multi vessel disease.\n                      J Interv Cardiol\n                      . 2016;29:241\u20137.","DOI":"10.1111\/joic.12293"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Tonino PA, Bruyne BD, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.\n                      N Engl J Med\n                      . 2009;360:213\u201324.","DOI":"10.1056\/NEJMoa0807611"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Bech JW, Bruyne BD, Pijls NJ, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis.\n                      Circulation\n                      . 2001;103:2928\u201334.","DOI":"10.1161\/01.CIR.103.24.2928"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Pumirat E, Cayla G, Simon T, et al. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction.\n                      N Engl J Med\n                      . 2021;385:297\u2013308.","DOI":"10.1056\/NEJMoa2104650"},{"key":"ref32","unstructured":"ClinicalTrials.gov. FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction (FLOWER-MI). ClinicalTrials.gov Identifier: NCT02943954. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02943954 (accessed 21 July 2021)."},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.\n                      Circulation\n                      . 2011;124:e574\u2013651.","DOI":"10.1161\/CIR.0b013e31823a5596"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).\n                      Eur Heart J\n                      . 2018;39:119\u201377.","DOI":"10.1093\/eurheartj\/ehx393"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC\/AHA\/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.\n                      Circulation\n                      . 2016;133:1135\u201347.","DOI":"10.1161\/CIR.0000000000000336"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Pavasini R, Biscaglia S, Barbato E, et al. Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.\n                      Eur Heart J\n                      . 2019;41:4103\u201310.","DOI":"10.1093\/eurheartj\/ehz896"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Osman M, Khan SU, Farjo PD, et al. Meta-analysis comparing complete versus infarct-related artery revascularization in patients with ST elevation myocardial infarction and multivessel coronary disease.\n                      Am J Cardiol\n                      . 2020;125:513\u201320.","DOI":"10.1016\/j.amjcard.2019.11.017"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Salih M, Ibrahim AM, Al-Akchar M, et al. Complete versus culprit only revascularization in patients presenting with ST segment elevation myocardial infarction: a meta-analysis of randomized control trials.\n                      Cardiovasc Revasc Med\n                      . 2020;21:1482\u20138.","DOI":"10.1016\/j.carrev.2020.05.019"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Atti V, Gwon Y, Narayanan MA, et al. Multivessel versus culprit-only revascularization in STEMI and multivessel coronary artery disease: meta-analysis of randomized trials.\n                      JACC Cardiovasc Interv\n                      . 2020;13:1571\u201382.","DOI":"10.1016\/j.jcin.2020.04.055"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Li Z, Zhou Y, Xu Q et al. Staged versus one-time complete revascularization with percutaneous coronary intervention in STEMI patients with multivessel disease: a systemic review and meta-analysis.\n                      PLoS One\n                      . 2017;12:e0169406.","DOI":"10.1371\/journal.pone.0169406"},{"key":"ref41","unstructured":"ClinicalTrials.gov. MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial (MULTISTARS AMI). ClinicalTrials.gov Identifier: NCT03135275. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03135275 (accessed 21 July 2021)."}],"container-title":["Heart International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/touchcardio.com\/cardiovascular-disease\/journal-articles\/comprehensive-review-of-complete-versus-culprit-only-revascularization-for-multivessel-disease-in-st-segment-elevation-myocardial-infarction\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:58:25Z","timestamp":1764745105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.touchcardio.com\/myocardial-infarction\/journal-articles\/comprehensive-review-of-complete-versus-culprit-only-revascularization-for-multivessel-disease-in-st-segment-elevation-myocardial-infarction\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"alternative-id":["HI.2021.15.1.54"],"URL":"https:\/\/doi.org\/10.17925\/hi.2021.15.1.54","relation":{},"ISSN":["2036-2579"],"issn-type":[{"type":"print","value":"2036-2579"}],"subject":[],"published":{"date-parts":[[2021]]}}}